MIP Search | Managing Intellectual Property

A new challenge for the patent system

Research into stem cells is leading to new demands on the patent system - and provoking resistance from protesters. Members of FICPI's Biotech Committee Helene Fagerlin, David Bannerman, Lola Bartoszewicz and Danny Huntington survey the latest developments in the US, Europe and elsewhere

Managing IP Correspondent, February 25 2005

Accessing genetic resources

Given the richness of Mexico's genetic resources, biopiracy is a serious threat in the country. Osvaldo Amaral of Olivares & Cia examines the existing and proposed legislation to protect local communities

Managing IP Correspondent, February 25 2005

Proposed regulations to adjust generic balance

The Canadian government has proposed changes to the regulations governing patented medicines and data exclusivity. David Heller and Adrian Zahl of Ridout & Maybee explain how the reforms will affect the research-based and generic industries

Managing IP Correspondent, February 25 2005

How to enforce your patent portfolio

Many biotechnology companies are looking hard at their patent portfolios to raise extra revenues. Orrick, Herrington & Sutcliffe's Craig Kaufman and Anne-Marie Dinius reveal how biotech companies can use the law to enhance their ability to enforce their patent rights

Managing IP Correspondent, February 25 2005

The road to regulatory approval for biogenerics

It has been hard for biogenerics to gain regulatory approval in Europe and the US, but the new EU regulatory regime could change that in Europe. Tim Powell and Ewan Nettleton of Bristows ask if the tide has turned

Managing IP Correspondent, February 25 2005

Europe's courts converge on non-literal infringement

In the light of recent cases on the scope of patent protection, William Cook, Peter Meyer and Francis van Velsen of Simmons & Simmons compare the approach of the English, German and Dutch courts

Managing IP Correspondent, February 25 2005

Harmonization due for pre-expiry trials in Europe

The scope of the experimental use exemption is a vital issue for both research-based and generic pharmaceutical companies. Ina Schreiber and Cyra Nargolwalla of Cabinet Plasseraud examine attempts to harmonize the law in Europe, and compare practice in France, Germany and the UK

Managing IP Correspondent, February 25 2005

How to win domain name cases

The Uniform Dispute Resolution Policy has made it easier for trade mark owners to win the rights to contested domain names. Frequent UDRP panellist Mark Partridge shows how victims of cybersquatting can maximize their chances of success

Managing IP Correspondent, February 01 2005

How to win at the new USPTO

As part of its wider reform efforts, the USPTO in late 2004 amended the form of its patent interference procedures. Barry Bretschneider and Matthew I Kreeger outline what the little-noticed changes will mean for patent owners

Managing IP Correspondent, February 01 2005

News focus: What’s in store for IP owners in 2005

International harmonization, trend-setting cases and new enforcement strategies are all on the IP menu for 2005. MIP spoke to practitioners worldwide to identify some of the expected events and trends. We also provide an overview of what’s happening where in 2005. James Nurton, Sam Mamudi and Emma Barraclough

Managing IP Correspondent, February 01 2005

Search results for